SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chijioke, C. P.
Right arrow Articles by Benedetti, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chijioke, C. P.
Right arrow Articles by Benedetti, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Lack of Acipimox-Digoxin Interaction in Patient Volunteers

Chioli Pascal Chijioke

Department of Clinical Pharmacology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK

Richard Martin Pearson

Department of Clinical Pharmacology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK

Strolin Benedetti

Department of Clinical Pharmacology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK

1 A study was carried out to find out if digoxin and acipimox interact.

2 Six elderly patients on digoxin were each given acipimox 150 mg three daily for a week, after informed consent. Digoxin and acipimox plasma concentrations and urinary excretion were measured after the first dose of acipimox and after a week of treatment.

3 Data were fitted to a one-compartment oral absorption model. Areas under the plasma concentration-time curve, plasma and renal clearances, and elimination half-life were computed.

4 There was no significant difference in digoxin plasma concentrations and kinetic parameters before and after acipimox administration. Acipimox kinetics were not affected by the concomitant ingestion of digoxin.

5 The patients' clinical condition remained stable during the study.

6 Thus there was no evidence for an adverse interaction between digoxin and acipimox in human subjects under the conditions of this study.

Human & Experimental Toxicology, Vol. 11, No. 5, 357-359 (1992)
DOI: 10.1177/096032719201100509


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement